Published in Mol Cancer Ther on March 01, 2007
Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov (2009) 4.16
Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis (2012) 1.60
Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment. Int J Mol Sci (2015) 0.99
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. Cancers (Basel) (2015) 0.99
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers. J Transl Med (2012) 0.98
Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog (2010) 0.97
Cyclin-dependent kinase inhibitors as potential targeted anticancer agents. Invest New Drugs (2009) 0.93
Emerging drug profile: cyclin-dependent kinase inhibitors. Leuk Lymphoma (2013) 0.89
CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Mol Cancer Ther (2012) 0.86
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells. BMC Cancer (2013) 0.85
Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development. ISRN Oncol (2013) 0.84
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines. Mol Cancer (2012) 0.83
Current and future trials of targeted therapies in cutaneous melanoma. Adv Exp Med Biol (2013) 0.81
Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2. Int J Mol Sci (2015) 0.79
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy. J Med Chem (2016) 0.79
Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma. J Transl Med (2013) 0.77
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphoma. Clin Lymphoma Myeloma Leuk (2015) 0.77
Anticancer Alkaloids from Trees: Development into Drugs. Pharmacogn Rev (2017) 0.75
BA-j as a novel CDK1 inhibitor selectively induces apoptosis in cancer cells by regulating ROS. Sci Rep (2015) 0.75
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chem Commun (Camb) (2017) 0.75
High-throughput production of human proteins for crystallization: the SGC experience. J Struct Biol (2010) 2.07
The PHD and chromo domains regulate the ATPase activity of the human chromatin remodeler CHD4. J Mol Biol (2012) 1.69
In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative. Cancer Chemother Pharmacol (2005) 1.60
Facile oxidation of aldehydes to acids and esters with Oxone. Org Lett (2003) 1.43
Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models. Cancer Chemother Pharmacol (2005) 1.33
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance. Eur J Cancer (2011) 1.28
In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00. Mol Cancer Ther (2007) 1.18
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem (2009) 1.14
Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J Antibiot (Tokyo) (2004) 1.06
Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J Nat Prod (2007) 1.06
Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS One (2007) 1.06
Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. Mol Cell Biochem (2006) 1.05
Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One (2012) 1.05
17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models. Anticancer Drugs (2004) 1.04
Cytotoxic bastadin 24 from the Australian sponge Ianthella quadrangulata. J Nat Prod (2008) 1.03
Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents. Cancer Genomics Proteomics (2009) 1.01
Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer (2012) 1.01
Cyclin-dependent kinase inhibitor, P276-00 induces apoptosis in multiple myeloma cells by inhibition of Cdk9-T1 and RNA polymerase II-dependent transcription. Leuk Res (2011) 0.99
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes. Anticancer Drugs (2005) 0.99
Antitumor activity of the marine natural product dibromophakellstatin in vitro. Bioorg Med Chem Lett (2006) 0.99
Comparative action of cobalt carbonyl complexes on cancer cells using human tumor xenografts. Anticancer Res (2002) 0.99
Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study. J Biol Inorg Chem (2009) 0.96
Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells. Stem Cells Dev (2012) 0.95
Atacamycins A-C, 22-membered antitumor macrolactones produced by Streptomyces sp. C38. J Antibiot (Tokyo) (2011) 0.95
Chinikomycins A and B: isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045. J Nat Prod (2005) 0.95
Synthesis and antitumor activity of 2,5-bis(3'-indolyl)-furans and 3,5-bis(3'-indolyl)-isoxazoles, nortopsentin analogues. Bioorg Med Chem (2010) 0.95
Antitumor activity of bis-indole derivatives. J Med Chem (2008) 0.94
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte. Bioorg Med Chem Lett (2010) 0.93
In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis. Mol Med (2012) 0.92
A family of multicyclic indolosesquiterpenes from a bacterial endophyte. Org Biomol Chem (2011) 0.92
Synthesis and antiproliferative activity of 2,5-bis(3'-indolyl)pyrroles, analogues of the marine alkaloid nortopsentin. Mar Drugs (2013) 0.92
Structural insights into functional overlapping and differentiation among myosin V motors. J Biol Chem (2013) 0.90
Arugosins G and H: prenylated polyketides from the marine-derived fungus Emericellanidulans var. acristata. J Nat Prod (2006) 0.90
Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro. Anticancer Res (2007) 0.90
Plasticity in gilvocarcin-type C-glycoside pathways: discovery and antitumoral evaluation of polycarcin V from Streptomyces polyformus. Org Biomol Chem (2008) 0.89
A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis. Eur J Pharmacol (2009) 0.87
CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Mol Cancer Ther (2012) 0.86
Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies. PLoS One (2013) 0.85
Lymphadenopathy resulting from acute toxoplasmosis mimicking relapse of non-Hodgkin's lymphoma on fluorodeoxyglucose positron emission tomography/computed tomography. J Cancer Res Ther (2012) 0.85
Composite adrenal medullary tumor: A rare cause of hypertension in a young male. Urol Ann (2011) 0.85
Puralpha activates PDGF-A gene transcription via interactions with a G-rich, single-stranded region of the promoter. Gene (2005) 0.85
Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation. N Biotechnol (2011) 0.85
Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells. Cancer Sci (2011) 0.84
Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs (2002) 0.84
Kandenols A-E, eudesmenes from an endophytic Streptomyces sp. of the mangrove tree Kandelia candel. J Nat Prod (2012) 0.84
MicroRNA-363 negatively regulates the left ventricular determining transcription factor HAND1 in human embryonic stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 0.83
Parimycin: isolation and structure elucidation of a novel cytotoxic 2,3-dihydroquinizarin analogue of gamma-indomycinone from a marine streptomycete isolate. J Antibiot (Tokyo) (2002) 0.83
A novel mTOR inhibitor is efficacious in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol (2008) 0.82
Novel derivatives of ISO-1 as potent inhibitors of MIF biological function. Bioorg Med Chem Lett (2009) 0.82
Doubly prenylated tryptamines: cytotoxicity, antimicrobial activity and cyclisation to the marine natural product flustramine A. Org Biomol Chem (2013) 0.82
Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK. ChemMedChem (2008) 0.81
Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery. Bioorg Med Chem Lett (2010) 0.81
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs. Bioorg Med Chem (2012) 0.81
Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine streptomycete. J Nat Prod (2009) 0.81
A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases. J Med Chem (2006) 0.80
Apralactone A and a New Stereochemical Class of Curvularins from the Marine-Derived Fungus Curvularia sp. European J Org Chem (2008) 0.80
Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor. Oncology (2007) 0.80
Novel leads from Heliotropium ovalifolium, 4,7,8-trimethoxy-naphthalene-2-carboxylic acid and 6-hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde show specific IL-6 inhibitory activity in THP-1 cells and primary human monocytes. Phytomedicine (2008) 0.80
Cyclic peroxides derived from the marine sponge Plakortis simplex. J Nat Prod (2005) 0.80
NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs. Bioorg Med Chem Lett (2009) 0.80
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer. Mol Cancer (2014) 0.80
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells. BMC Cancer (2011) 0.80
Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention. Cancer Genomics Proteomics (2007) 0.80
Epoxyphomalin A and B, prenylated polyketides with potent cytotoxicity from the marine-derived fungus Phoma sp. Org Lett (2009) 0.79
Isolation and functional characterization of alpha-smooth muscle actin expressing cardiomyocytes from embryonic stem cells. Cell Physiol Biochem (2010) 0.78
Divergolides A-D from a mangrove endophyte reveal an unparalleled plasticity in ansa-macrolide biosynthesis. Angew Chem Int Ed Engl (2011) 0.78
All-trans retinoic acid and basic fibroblast growth factor synergistically direct pluripotent human embryonic stem cells to extraembryonic lineages. Stem Cell Res (2012) 0.78
Pachydictyols B and C: new diterpenes from Dictyota dichotoma Hudson. Mar Drugs (2013) 0.78
Structure, derivatization, and antitumor activity of new griseusins from Nocardiopsis sp. J Med Chem (2007) 0.77
Gene signature-based prediction of tumor response to cyclophosphamide. Cancer Genomics Proteomics (2007) 0.77
Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma. J Transl Med (2013) 0.77
Antiarol cinnamate and africanoside, a cinnamoyl triterpene and a hydroperoxy-cardenolide from the stem bark of Antiaris africana. Planta Med (2010) 0.77
Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.77
Hydrazidomycins, cytotoxic alkylhydrazides from Streptomycesatratus. Bioorg Med Chem Lett (2011) 0.77
Design and synthesis of novel furoquinoline based inhibitors of multiple targets in the PI3K/Akt-mTOR pathway. Bioorg Med Chem Lett (2008) 0.77
AMT: preclinical pharmacology studies. Int J Oncol (2009) 0.77
Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitors. Bioorg Med Chem Lett (2009) 0.77
Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models. PLoS One (2013) 0.77
Medium-throughput production of recombinant human proteins: ligation-independent cloning. Methods Mol Biol (2014) 0.76
Molecular editing and biological evaluation of amphidinolide X and Y. Chemistry (2009) 0.76
Hygrobafilomycin, a cytotoxic and antifungal macrolide bearing a unique monoalkylmaleic anhydride moiety, from Streptomyces varsoviensis. J Antibiot (Tokyo) (2010) 0.76
Elaiomycins D-F, antimicrobial and cytotoxic azoxides from Streptomyces sp. strain HKI0708. J Nat Prod (2012) 0.76